Aspex Management HK Ltd Boosts Stock Position in Synopsys, Inc. $SNPS

Aspex Management HK Ltd increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 135.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,517,582 shares of the semiconductor company’s stock after acquiring an additional 871,687 shares during the period. Synopsys comprises about 15.9% of Aspex Management HK Ltd’s portfolio, making the stock its 2nd largest position. Aspex Management HK Ltd owned about 0.82% of Synopsys worth $748,760,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in SNPS. Alpine Bank Wealth Management lifted its position in shares of Synopsys by 89.3% in the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 25 shares during the last quarter. TFC Financial Management Inc. lifted its position in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after acquiring an additional 50 shares during the last quarter. Millstone Evans Group LLC acquired a new position in Synopsys in the 3rd quarter valued at $27,000. SOA Wealth Advisors LLC. bought a new stake in shares of Synopsys in the third quarter valued at about $28,000. Finally, McIlrath & Eck LLC bought a new stake in shares of Synopsys during the 3rd quarter valued at $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Citigroup initiated coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. Rosenblatt Securities decreased their target price on Synopsys from $560.00 to $530.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Morgan Stanley reissued an “equal weight” rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Bank of America raised Synopsys from an “underperform” rating to a “neutral” rating and decreased their price objective for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Finally, The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $531.00.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider directly owned 11,959 shares in the company, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 4,157 shares of company stock worth $1,945,036. 0.56% of the stock is owned by insiders.

Synopsys Stock Performance

Synopsys stock opened at $412.63 on Friday. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The firm’s 50 day simple moving average is $461.93 and its 200 day simple moving average is $464.57. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $79.04 billion, a PE ratio of 64.07, a price-to-earnings-growth ratio of 3.41 and a beta of 1.15.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The company’s quarterly revenue was up 65.6% compared to the same quarter last year. During the same period in the prior year, the company earned $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.